December 23, 2008

Embracing Change in a Challenged Healthcare Industry

At Columbia Business School's 5th Annual Healthcare Conference, industry leaders said they are looking for ways to drive innovation.

Read post
March 10, 2009

Rationale and Risks of Merck's $41 Billion Acquisition of Schering-Plough

Yesterday's announcement marks the second time this year that two pharmaceutical giants have agreed to merge. What is driving the consolidation, and what are the risks?

Read post
January 27, 2009

A Perspective on the Pfizer-Wyeth Merger

Why did Pfizer pursue this strategy? And will the acquisition encourage other Big Pharma players to take a similar approach?

Read post 1 Comment
November 20, 2009

New Healthcare Paradigm: Technology, Value and Emergence

At the 6th Annual Healthcare Conference, industry leaders said they are focused on innovation, value-rich offerings and the emergence of new global markets and technologies.

Read post
August 18, 2008

What Next For Big Pharma?

As growth slows in the pharmaceutical sector, shareholders are putting pressure on companies and their executives to make some difficult decisions.

Read post 4 Comments